Cell-Free DNA Analysis by Whole-Exome Sequencing for Hepatocellular Carcinoma: A Pilot Study in Thailand

Cell-Free DNA Analysis by Whole-Exome Sequencing for Hepatocellular Carcinoma: A Pilot Study in Thailand

Cell-free DNA (cfDNA) has been used as a non-invasive biomarker for detecting cancer-specific mutations. However, the mutational profile of cfDNA in Thai patients with hepatocellular carcinoma (HCC) has not been investigated. Here, we demonstrated the utility of using whole-exome sequencing (WES) of...

Full description

Bibliographic Details
Main Authors: Pattapon Kunadirek, Natthaya Chuaypen, Piroon Jenjaroenpun, Thidathip Wongsurawat, Nutcha Pinjaroen, Pongserath Sirichindakul, Intawat Nookaew, Pisit Tangkijvanich
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
hepatocellular carcinoma
cell-free DNA
whole-exome sequencing
biomarker
Thailand
Oxford Nanopore Technologies
Online Access:https://www.mdpi.com/2072-6694/13/9/2229

Internet

https://www.mdpi.com/2072-6694/13/9/2229

Similar Items